C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
Top Cited Papers
Open Access
- 15 January 2010
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 375 (9709), 132-140
- https://doi.org/10.1016/s0140-6736(09)61717-7
Abstract
No abstract availableKeywords
Funding Information
- British Heart Foundation
- Bupa Foundation
- GlaxoSmithKline
- Medical Research Council
This publication has 51 references indexed in Scilit:
- Major Lipids, Apolipoproteins, and Risk of Vascular DiseaseJAMA, 2009
- Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular MortalityJAMA, 2009
- Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart DiseaseJAMA, 2009
- Correcting for multivariate measurement error by regression calibration in meta‐analyses of epidemiological studiesStatistics in Medicine, 2009
- Inflammation and Hemostasis Biomarkers for Predicting Stroke in Postmenopausal Women: The Women's Health Initiative Observational StudyJournal of Stroke and Cerebrovascular Diseases, 2008
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinThe New England Journal of Medicine, 2008
- Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohortsInternational Journal of Epidemiology, 2008
- EPIC-Heart: The cardiovascular component of a prospective study of nutritional, lifestyle and biological factors in 520,000 middle-aged participants from 10 European countriesEuropean Journal of Epidemiology, 2007
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseThe New England Journal of Medicine, 2005
- Acute-Phase Proteins and Other Systemic Responses to InflammationThe New England Journal of Medicine, 1999